Afrezza inhaled insulin

Afrezza Inhaled Insulin – Patient Access Information

Overview

Afrezza inhaled insulin is a rapid-acting inhalable insulin used in the management of diabetes mellitus under medical supervision. Unlike injectable insulin, Afrezza is administered using an insulin inhaler, allowing insulin to be absorbed through the lungs for fast blood glucose control around mealtimes.

Afrezza insulin is supplied under named patient or case-based access programs, where treatment is prescribed by a licensed healthcare professional for an individual patient with a documented clinical requirement. It is not supplied as a retail or over-the-counter medicine.

---

Uses of Afrezza Inhaled Insulin

Afrezza inhaled insulin is used for:

• Mealtime blood glucose control in diabetes

• Rapid insulin action at the start of meals

• Patients who require an alternative to injectable insulin, based on physician assessment

Treatment suitability, dosage, and monitoring are determined solely by the treating physician.

---

Benefits of Afrezza Insulin

In appropriate patients, inhaled insulin Afrezza may offer:

• Rapid onset of insulin action after insulin inhale administration

• Needle-free insulin delivery via an Afrezza inhaler

• Flexible mealtime insulin management when prescribed appropriately

Afrezza does not replace long-acting (basal) insulin where basal insulin is clinically required and must be used strictly as part of a physician-guided diabetes management plan.

---

Afrezza Generic Name & Composition

The Afrezza generic name is human insulin formulated as a dry powder for oral inhalation. It is delivered using a dedicated inhalation device designed to ensure accurate dosing and pulmonary absorption.

---

Side Effects & Safety Information

As with all insulin therapies, side effects may occur. Patients should be monitored regularly by their healthcare provider.

Possible side effects include:

• Cough or throat irritation

• Low blood sugar (hypoglycemia)

• Headache or fatigue

• Changes in lung function

• Upper respiratory tract symptoms

Afrezza inhaled insulin is not recommended for patients with chronic lung diseases such as asthma or COPD. Pulmonary function testing is typically required before and during treatment.

---

How Afrezza Inhaled Insulin Is Used

• Afrezza insulin is administered using a dedicated insulin inhaler

• It is inhaled at the beginning of meals as prescribed

• Dosage is individualized based on blood glucose monitoring and physician guidance

• Patients must not alter dosing without medical advice

---

How Afrezza Inhalable Insulin Works

After insulin inhale, Afrezza insulin particles are absorbed rapidly through the lungs into the bloodstream. This allows fast-acting insulin availability to help control post-meal blood glucose levels.

---

Named Patient Supply Through Oddway International

Oddway International facilitates named patient access to Afrezza inhaled insulin for:

• Hospitals and clinics

• Treating physicians

• Licensed importers

• Individual patients with valid prescriptions

Supply is managed on a case-by-case basis, in accordance with destination-country regulations, prescription requirements, and ethical pharmaceutical supply standards.

Supply Assurances

• Regulatory-compliant documentation handling

• Controlled and validated logistics

• Sourcing from verified manufacturers

• Dedicated coordination for patient access cases